OBJECTIVE: To investigate the effect of cardiac output and liver blood flow on propofol concentrations in critically ill patients in the intensive care unit. METHODS: Five medical/surgical critically ill patients were enrolled in this preliminary study. Liver blood flow was measured using sorbitol. The cardiac output was measured by bolus thermodilution. NONMEM ver. V was applied for propofol pharmacokinetic analysis. RESULTS: The clearance of propofol was positively influenced by the liver blood flow (P < 0.005), whereas no significant correlation between cardiac output and propofol clearance was found. A correlation between liver blood flow and cardiac output or cardiac index could not be assumed in this patient group. CONCLUSIONS: Liver blood flow is a more predictive indicator than cardiac output for propofol clearance in critically ill patients when the techniques of hepatic sorbitol clearance and bolus thermodilution, respectively, are used. Further study is needed to determine the role played by liver blood flow and cardiac output on the pharmacokinetics of highly extracted drugs in order to reduce the observed high interindividual variabilities in response in critically ill patients.
OBJECTIVE: To investigate the effect of cardiac output and liver blood flow on propofol concentrations in critically ill patients in the intensive care unit. METHODS: Five medical/surgical critically ill patients were enrolled in this preliminary study. Liver blood flow was measured using sorbitol. The cardiac output was measured by bolus thermodilution. NONMEM ver. V was applied for propofol pharmacokinetic analysis. RESULTS: The clearance of propofol was positively influenced by the liver blood flow (P < 0.005), whereas no significant correlation between cardiac output and propofol clearance was found. A correlation between liver blood flow and cardiac output or cardiac index could not be assumed in this patient group. CONCLUSIONS: Liver blood flow is a more predictive indicator than cardiac output for propofol clearance in critically ill patients when the techniques of hepatic sorbitol clearance and bolus thermodilution, respectively, are used. Further study is needed to determine the role played by liver blood flow and cardiac output on the pharmacokinetics of highly extracted drugs in order to reduce the observed high interindividual variabilities in response in critically ill patients.
Authors: M J Kemme; J Burggraaf; R C Schoemaker; S Paulson; A Karim; E G Lentjes; A Childs; R A Braeckman; A F Cohen Journal: Clin Pharmacol Ther Date: 2000-05 Impact factor: 6.875
Authors: S Harvey; K Stevens; D Harrison; D Young; W Brampton; C McCabe; M Singer; K Rowan Journal: Health Technol Assess Date: 2006-08 Impact factor: 4.014
Authors: M Y M Peeters; L J Bras; J DeJongh; R M J Wesselink; L P H J Aarts; M Danhof; C A J Knibbe Journal: Clin Pharmacol Ther Date: 2007-08-08 Impact factor: 6.875
Authors: Marcus A Björnsson; Ake Norberg; Sigridur Kalman; Mats O Karlsson; Ulrika S H Simonsson Journal: J Pharmacokinet Pharmacodyn Date: 2010-04-23 Impact factor: 2.745
Authors: Agnieszka Bienert; Krzysztof Kusza; Katarzyna Wawrzyniak; Edmund Grześkowiak; Zenon J Kokot; Jan Matysiak; Tomasz Grabowski; Anna Wolc; Paweł Wiczling; Miłosz Regulski Journal: J Pharmacokinet Pharmacodyn Date: 2010-06-11 Impact factor: 2.745
Authors: Agnieszka Bienert; Paweł Sobczyński; Katarzyna Młodawska; Roma Hartmann-Sobczyńska; Edmund Grześkowiak; Paweł Wiczling Journal: J Pharmacokinet Pharmacodyn Date: 2020-08-25 Impact factor: 2.745